Bolt Biotherapeutics

Filed a patent for "thienoazepine immunoconjugates, and uses thereof" on Thu, December 15, 2022

Filed a patent for "cancer combination treatment method" on Thu, December 15, 2022

Filed a patent for "anti-claudin, bis-benzimidazole sting agonist immunoconjugates, and uses thereof" on Tue, December 20, 2022

Filed a patent for "aza-benzazepine immunoconjugates, and uses thereof" on Tue, February 14, 2023

Filed a patent for "aza-bicyclic sting agonist immunoconjugates, and uses thereof" on Fri, March 3, 2023

Filed a patent for "anti-dectin-2 antibody combination therapy" on Thu, April 13, 2023

Filed a patent for "tlr agonist immunoconjugates with cysteine-mutant antibodies, and uses thereof" on Tue, April 16, 2024

Filed a patent for "asymmetric bis-benzimidazole sting agonist immunoconjugates and uses thereof" on Mon, April 1, 2024

Filed a patent for "bis-benzimidazole sting agonist immunoconjugates, and uses thereof" on Thu, December 21, 2023

Filed a patent for "elastase-substrate, peptide linker immunoconjugates, and uses thereof" on Thu, September 21, 2023

Filed a patent for "pyrazoloazepine immunoconjugates, and uses thereof" on Thu, August 24, 2023

Filed a patent for "anti-pd-l1 immunoconjugates, and uses thereof" on Thu, February 1, 2024

Filed a patent for "anti-cea immunoconjugates, and uses thereof" on Thu, May 25, 2023

Filed a patent for "anti-her2 immunoconjugates, and uses thereof" on Thu, February 8, 2024

Filed a patent for "anti-her2 immunoconjugates, and uses thereof" on Thu, March 21, 2024

Filed a patent for "anti-dectin-2 antibodies" on Thu, December 21, 2023

Filed a patent for "2-amino-4-carboxamide-benzazepine immunoconjugates, and uses thereof" on Thu, June 20, 2024

Filed a patent for "2-amino-4-carboxamide-benzazepine immunoconjugates, and uses thereof" on Thu, September 21, 2023

Filed a patent for "amide-linked, aminobenzazepine immunoconjugates, and uses thereof" on Thu, November 3, 2022

Filed a patent for "macromolecule-supported thienoazepine compounds, and uses thereof" on Thu, August 17, 2023

Filed a patent for "anti-pd-l1 antibodies" on Thu, March 2, 2023

Filed a patent for "anti-pd-l1 antibodies" on Thu, March 23, 2023

Filed a patent for "antibody adjuvant conjugates" on Thu, April 13, 2023

Filed a patent for "cancer treatment methods" on Thu, June 1, 2023